ARCH Venture Partners IX LLC insider trades

Open-market stock purchases and sales by ARCH Venture Partners IX LLC, 10% Owner at Lyell Immunopharma, Inc, from SEC Form 4 filings since Feb 12, 2019.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -56%.

Recent trades

DateStockTradeValue
Mar 6, 2026LYEL Lyell Immunopharma, IncBought$12.5M

Companies traded

  • LYEL Lyell Immunopharma, Inc: 1 buy, last Mar 6, 2026
  • VIR Vir Biotechnology, Inc: 1 buy, last Sep 6, 2022
  • BEAM Beam Therapeutics Inc: other filings, last Jun 30, 2021
  • KRTX Karuna Therapeutics, Inc: 1 buy, last Apr 13, 2021
  • GOSS Gossamer Bio, Inc: other filings, last Feb 12, 2019

Get free alerts when ARCH Venture Partners IX LLC files a new trade →